August 15, 2023 03:08 PM EDT
FDA+

FDA fi­nal­izes 2014 guid­ance on in­formed con­sent in tri­als, with more up­dates com­ing soon

Zachary Brennan

Senior Editor

The FDA on Tues­day fi­nal­ized guid­ance from 2014 to help spon­sors, IRBs and in­ves­ti­ga­tors meet all of their in­formed con­sent re­quire­ments when it comes to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times